Skip to main content
. 2020 Aug 27;28(10):1243–1252. doi: 10.1016/j.jsps.2020.08.015

Fig. 1.

Fig. 1

Schematic diagram of targets with pathogenesis pathway for broad-spectrum antiviral agents, anti-inflammatory and immuno-modulatory agents in treatment of COVID-19.